Compare Bath & Body Works Inc (BBWI) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Novavax Inc — how do they compare? Bath & Body Works Inc trades at $19 (market cap $3.81B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Bath & Body Works Inc is far larger — about 2.9× Novavax Inc's market cap, and Bath & Body Works Inc pays a 4.24% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BBWI | NVAX | |
|---|---|---|
Market Cap | $3.81B | $1.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $11.19 |
52-Week Low | $14.85 | $6.22 |
Enterprise Value | $7.70B | $889.30M |
Dividend Yield | 4.24% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
